$28.3M to Leidos
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
- Company
- LDOSLeidos
- Recipient name in record
- LEIDOS BIOMEDICAL RESEARCH INC
- Awarded by
- Department of Health and Human Services · National Institutes of Health
- Value
- $28.3M
- Start date
- 23 Sep 2019
- End date
- 31 Mar 2031
- Award ID
- 75N91019F00138
- Source
- View official record on USAspending.gov ↗
The match between the recipient name and the listed company is made by StockRoz and can contain errors.